Expert Speaker Faculty

Take a look at the esteemed speaker faculty for the Amylin-Based Therapeutics Summit.

Pharma Leaders Driving Discovery to Clinical Strategy
Biotech Innovators Advancing Next-Generation Amylin Therapies
Academics & Investors Translating Science into Clinical Impact

Pharma Leaders Driving Discovery to Clinical Strategy

Headshot of Daniel Briere, Senior Director at Eli Lilly, speaking at the Amylin-Based Therapeutics Summit

Daniel Briere

Director
Eli Lilly & Co.
Headshot of Kirsten Raun, Vice President, Scientific at Novo Nordisk, speaking at the Amylin-Based Therapeutics Summit

Kirsten Raun

Vice President - Scientific
Novo Nordisk
Headshot of Anna Secher, Director, Scientific at Novo Nordisk, speaking at the Amylin-Based Therapeutics Summit

Anna Secher

Director - Scientific
Novo Nordisk
Headshot of Gabriel Smolarz, Vice President, US Medical Affairs and Medical Advisor at Zealand Pharma, at the Amylin-Based Therapeutics Summit

Gabriel Smolarz

Vice President
Zealand Pharma A/S

Biotech Innovators Advancing Next-Generation Amylin Therapies

Headshot of Mads Tang-Christensen, Chief Scientific Officer at Antag Therapeutics, at the Amylin-Based Therapeutics Summit

Mads Tang-Christensen

Chief Scientific Officer
Antag Therapeutics
Headshot of Alice Fitzpatrick, Director, Gene Therapy at Fractyl Laboratories, at the Amylin-Based Therapeutics Summit

Alice Fitzpatrick

Director - Gene Therapy
Fractyl Laboratories Inc.
Headshot of Bin Zhu, Vice President, Business Development at GeneScience Pharmaceuticals, at the Amylin-Based Therapeutics Summit

Bin Zhu

VP, BD
GeneScience Pharm.
Headshot of Andrew Young, Chief Scientific and Medical Officer at I2O Therapeutics, at the Amylin-Based Therapeutics Summit

Andrew Young

Chief Scientific & Medical Officer
I2O Therapeutics
Headshot of Martin Brenner, Chief Executive Officer and Chief Scientific Officer at iBio, at the Amylin-Based Therapeutics Summit

Martin Brenner

Chief Executive & Scientific Officer
iBio
Headshot of Cody Moore, Director, Platform Development at iBio, speaking at the Amylin-Based Therapeutics Summit

Cody Moore

Director - Platform Development
iBio
Headshot of Cristina Rondinone, Founder and Chief Executive Officer at Pep2Tango, at the Amylin-Based Therapeutics Summit

Cristina Rondinone

Founder & Chief Executive Officer
Pep2Tango Therapeutics
Headshot of Ved Srivastava, Chief Scientific Officer at Perpetual Medicines, speaking at the Amylin-Based Therapeutics Summit

Ved Srivastava

Chief Technology Officer
Perpetual Medicines
Headshot of Brent Meadows, Chief Business Officer at Senovia Biosciences, at the Amylin-Based Therapeutics Summit

Brent Meadows

Chief Business Officer
Senovia Biosciences

Academics & Investors Translating Science into Clinical Impact

Headshot of Jay Olson, Research Analyst at Oppenheimer & Company, speaking at the Amylin-Based Therapeutics Summit

Jay Olson

Research Analyst
Oppenheimer & Company
Headshot of Debbie Hay, Professor of Pharmacology at Otago University, speaking at the Amylin-Based Therapeutics Summit

Debbie Hay

Professor - Pharmacology
Otago University
Augen

Augen Pioszak

Associate Professor, Department of Biochemistry & Physiology
University of Oklahoma
Headshot of Thomas Lutz, Professor at the University of Zurich, speaking at the Amylin-Based Therapeutics Summit

Thomas Lutz

Director & Professor - Institute of Veterinary Physiology
University of Zurich
12 (1)

Explore the Agenda

Dive into the latest advances in amylin drug development, from receptor biology and translational challenges to clinical differentiation, combination strategies and commercial opportunity through presentations, roundtables and panel discussions.

View Presentations & Speakers
12

Partner With Us

Position your company alongside leading amylin developers and showcase the tools, technologies and services helping biopharma accelerate next-generation amylin programmes.

Explore Sponsorship Options
21

Join Amylin Experts

Connect with the scientists, clinicians and decision-makers shaping the future of amylin therapeutics across discovery, preclinical, clinical and commercial development.

Register Now